Inhibition of tomato fruit ripening by 1-MCP, WORTMANNIN (cas 19545-26-7) and hexanal is associated with a decrease in transcript levels of phospholipase D and other ripening related genes

Add time:08/24/2019    Source:sciencedirect.com

Membrane deterioration is an inherent aspect of the advancement in senescence and loss in fruit quality during storage. Postharvest technologies used for extending shelf life and quality are targeted to reduce membrane damage through downregulating or blocking ethylene action. In this study, mature green tomato fruit were treated with inhibitors of ethylene receptor (ETR), phosphatidylinositol 3-kinase (PI3K) and phospholipase D (PLD), all recognized to be targets of regulation of fruit ripening. The inhibitors used included 1-methylcyclopropene (1-MCP, an ethylene receptor blocker), WORTMANNIN (cas 19545-26-7) (an inhibitor of PI3K), and hexanal (a PLD inhibitor). Fruit were treated at optimal levels of the inhibitors and were stored at 21 °C for 10 days. Color development was strongly delayed in wortmannin treated tomatoes just as in 1-MCP treated fruit; while, changes in respiration, firmness and ethylene evolution were very similar to that of control fruit. Hexanal delayed the initiation of these changes; while 1-MCP and wortmannin blocked the ripening process. Changes in expression levels of key genes involved in ethylene signalling, phosphoinositide metabolism, and lycopene synthesis that occurred in response to inhibitors, suggested potential roles for PI3K and PLD in ethylene signalling. Furthermore, fruit treated with all the three inhibitors showed a marked reduction in PLD transcript levels; suggesting that, regulation of PLD gene expression is a common critical regulatory point that regulates ripening. Lowered PLD levels may reduce membrane lipid catabolism and the generation of phosphatidic acid (PA), an intermediate in ethylene signalling regulation through downstream components.

We also recommend Trading Suppliers and Manufacturers of WORTMANNIN (cas 19545-26-7). Pls Click Website Link as below: cas 19545-26-7 suppliers

Prev:Pretreatment with WORTMANNIN (cas 19545-26-7) alleviates lipopolysaccharide/d-galactosamine-induced acute liver injury
Next:WORTMANNIN (cas 19545-26-7) potentiates the combined effect of etoposide and cisplatin in human glioma cells)